Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 7/20 | 0.85 |
| ▸ | NPC1 | O15118 | 6/20 | 0.85 |
| ▸ | MAPT | P10636 | 2/20 | 0.85 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.85 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.70 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.69 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.69 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.69 |
| ▸ | NAMPT | P43490 | 2/20 | 0.66 |
| ▸ | HTT | P42858 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.65 |
| ▸ | HPGD | P15428 | 1/20 | 0.65 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.65 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.63 |
| ▸ | MEN1 | O00255 | 2/20 | 0.63 |
| ▸ | POLB | P06746 | 2/20 | 0.63 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19500970 | 0.93 | NPC1 (0.80) | RAB9ANPC1MAPTSMN1; SMN2PTPN1 | |
| SCHEMBL16589432 | 0.93 | PTPN1 (0.80) | RAB9ANPC1MAPTSMN1; SMN2PTPN1 | |
| SCHEMBL13211986 | 0.93 | NPC1 (0.80) | RAB9ANPC1MAPTSMN1; SMN2PTPN1 | |
| SCHEMBL82305 | 0.92 | RAB9A (1.00) | RAB9ANPC1MAPTSMN1; SMN2PTPN1 | |
| Iodide SCHEMBL30758618 | 0.90 | RAB9A (0.96) | RAB9ANPC1MAPTSMN1; SMN2PTPN1 | |
| SCHEMBL12310125 | 0.90 | RAB9A (1.00) | RAB9ANPC1MAPTSMN1; SMN2TDP1 | |
| SCHEMBL14580374 | 0.90 | RAB9A (1.00) | RAB9ANPC1MAPTSMN1; SMN2TDP1 | |
| SCHEMBL822378 | 0.90 | RAB9A (1.00) | RAB9ANPC1MAPTSMN1; SMN2TDP1 | |
| SCHEMBL27181403 | 0.90 | RAB9A (1.00) | RAB9ANPC1MAPTSMN1; SMN2TDP1 | |
| SCHEMBL15214321 | 0.90 | RAB9A (1.00) | RAB9ANPC1MAPTSMN1; SMN2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240316015-A1 | COMPOSITION AND METHOD FOR TREATING TUMORS | NATURAL MEDICINE INSTITUTE OF ZHEJIANG YANGSHENGTANG CO., LTD. (CN) | 2024-09-26 | — | — | US | claimed |
| EP-4282413-A1 | COMPOSITION AND METHOD FOR TREATING TUMORS | NATURAL MEDICINE INSTITUTE OF ZHEJIANG YANGSHENGTANG CO., LTD. (CN) | 2023-11-29 | — | — | EP | claimed |
| CN-116462604-A | Synthesis method of four quaternary ammonium salt derivatives and application of four quaternary ammonium salt derivatives as anti-staphylococcus aureus infection agents | 西北工业大学宁波研究院 | 2023-07-21 | — | — | CN | claimed |
| EP-4140480-A1 | DRUG COMBINATION AND USE THEREOF | NATURAL MEDICINE INSTITUTE OF ZHEJIANG YANGSHENGTANG CO., LTD. (CN) | 2023-03-01 | — | — | EP | claimed |
| WO-2022156727-A1 | COMPOSITION AND METHOD FOR TREATING TUMORS | 浙江养生堂天然药物研究所有限公司 | 2022-07-28 | — | — | WO | claimed |
| WO-2021213455-A1 | DRUG COMBINATION AND USE THEREOF | 浙江养生堂天然药物研究所有限公司 (CN) | 2021-10-28 | — | — | WO | claimed |
| CN-111163761-A | Targeted drugs related to trimethylamine and/or trimethylamine-N-oxide | 普梭梅根公司 | 2020-05-15 | — | — | CN | claimed |
| US-6630512-B2 | Antiinflammatory agents; autoimmune disease | BIOGEN, INC. | 2003-10-07 | — | — | US | claimed |
| US-20030018016-A1 | Cell adhesion inhibitors | BIOGEN IDEC MA, INC. | 2003-01-23 | — | — | US | claimed |
| EP-0805796-B1 | CELL ADHESION INHIBITORS | BIOGEN INC (US) | 2002-12-11 | — | — | EP | claimed |
| US-6376538-B1 | ANTIINFLAMMATORY AGENTS; AUTOIMMUNE DISEASES | BIOGEN, INC. | 2002-04-23 | — | — | US | claimed |
| US-20250326709-A1 | THE MICROWAVE-ASSISTED CATALYTIC AMIDATION OF ORGANIC AMINES WITH CARBOXYLIC ACIDS | PURDUE RESEARCH FOUNDATION (US) | 2025-10-23 | — | — | US | disclosed |
| CN-119264004-A | Light-induced iridium metal catalytic synthesis method of N-aryl amide | 平顶山学院 | 2025-01-07 | — | — | CN | disclosed |
| US-20240316015-A1 | COMPOSITION AND METHOD FOR TREATING TUMORS | NATURAL MEDICINE INSTITUTE OF ZHEJIANG YANGSHENGTANG CO., LTD. (CN) | 2024-09-26 | — | — | US | disclosed |
| WO-2024151471-A1 | HIGH-THROUGHPUT ASSAY BASED ON LIGAND-BIASED STRUCTURAL DYNAMICS RESPONSE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2024-07-18 | — | — | WO | disclosed |
| US-5017686-A | Production of aromatic polyamide using a fused ring stabilizer | HUELS AKTIENGESELLSCHAFT (DE) | 1991-05-21 | — | — | US | disclosed |
| US-5015680-A | Production of a thermoplastically processable, aromatic polyamide using a 4-phenoxypyridine stabilizer | HUELS AKTIENGESELLSCHAFT (DE) | 1991-05-14 | — | — | US | disclosed |
| US-4952662-A | Molding compounds comprising a thermoplastically processible, aromatic polyamide | Huels Aktiengaellscaft (DE) | 1990-08-28 | — | — | US | disclosed |
| US-4069340-A | ARYLOXY DIMETHYL IMMONIUM CHLORIDES FROM DIMETHYL FORMAMIDE AND CORRESPONDING ARYL CHLOROFORMATES | HOOKER CHEMICALS & PLASTICS CORPORATION (US) | 1978-01-17 | — | — | US | disclosed |
| US-3983178-A | Immonium salts and derivatives thereof | HOOKER CHEMICALS & PLASTICS CORPORATION (US) | 1976-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240316015-A1 | COMPOSITION AND METHOD FOR TREATING TUMORS | PDE4B, PDE4A, PDE4C | RAB9A 2882/4885NPC1 4322/4885MAPT 2345/4885 |
| US-20250326709-A1 | THE MICROWAVE-ASSISTED CATALYTIC AMIDATION OF ORGANIC AMINES WITH CARBOXYLIC ACIDS | NAAA, OAT, PAM | RAB9A 2702/4885NPC1 4725/4885MAPT 470/4885 |
| US-20030018016-A1 | Cell adhesion inhibitors | ICAM1, VCAM1, EPCAM | RAB9A 1779/4885NPC1 2649/4885MAPT 2771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.